In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
MSK hematologist-oncologist Dr. Lia Palomba
Article
FDA Approves Marginal Zone Lymphoma CAR T Cell Treatment

Read about a new CAR T cell therapy now approved for marginal zone lymphoma (MZL).
MSK medical oncologist Komal Jhaveri.
Article
Imlunestrant With or Without Abemaciclib Effective in Treating ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy

Read about a new treatment for people with some ER+, HER2- advanced breast cancers.
MSK medical oncologist and bladder cancer specialist Jonathan Rosenberg
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients

A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.
MSK medical oncologist and breast cancer specialist Dr. Komal Jhaveri.
Article
Antibody-Drug Conjugate for Endocrine-Refractory and Chemotherapy Naive HR+, HER2- Breast Cancer

Read about an antibody-drug conjugate treatment for HR+, HER2- breast cancer.
MSK multiple myeloma specialist Urvy Shah
Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts

Learn how eating a plant-based diet may prevent MGUS and smoldering myeloma from developing into multiple myeloma, according to MSK research.
Dr. Urvi Shah is seen smiling at the camera.
MSK Research Reveals Connection Between Diet and Cancer

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.
MSK cellular therapist Heather Landau
Clinical Update
CAR T Cell Therapy for Light Chain (AL) Amyloidosis Achieves Strong Results

Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.
MSK myeloma specialist and cellular therapist Saad Usmani, MD
Article
New Extramedullary Myeloma Treatment With Bispecific Antibodies Improves Survival Dramatically

Read about a new treatment combining bispecific antibodies that is effective against extramedullary myeloma.
Michael with his granddaughter on a boat
New Treatment for Relapsed Follicular Lymphoma Approved by FDA After MSK-Led Clinical Trial

A phase 3 trial led by MSK showed that adding epcoritamab to traditional treatment for follicular lymphoma benefits patients. Epcoritamab received FDA approval based on the findings.
MSK breast cancer patient Majiel Baker is seen at the beach with her husband and children.
Cancer Care Worth Traveling For: Why People Come to MSK From Across the Country

Learn why over 5,000 people a year travel more than 150 miles to MSK for cancer care, including resources for the specific needs of traveling patients and their loved ones.